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Abstract
Interleukin (IL)-18 is a cytokine isolated as an important modulator of immune responses and subsequently shown
to be pleiotropic. IL-18 and its receptors are expressed in the central nervous system (CNS) where they participate
in neuroinflammatory/neurodegenerative processes but also influence homeostasis and behavior. Work on IL-18
null mice, the localization of the IL-18 receptor complex in neurons and the neuronal expression of decoy isoforms
of the receptor subunits are beginning to reveal the complexity and the significance of the IL-18 system in the
CNS. This review summarizes current knowledge on the central role of IL-18 in health and disease.
Introduction
Interleukin (IL)-18 was isolated in 1995 as a co-factor
that, in synergism with IL-12, stimulated the production
of gamma interferon (INF-g) in Th1 cells [1]. Since then
extensive in vitro and in vivo studies have identified IL-
18 as an important link between innate and adaptive
immune responses and a regulator of both cellular and
humoral immunity [2-4]. Constitutively produced as an
inactive precursor by several cell types IL-18 is secreted
in its active form following maturation by caspase 1 in
response to inflammatory and infectious stimuli. In
addition to its effects on Th1 cells, IL-18 is a strong sti-
mulator of the activity of natural killer cells alone or in
combination with IL-15, and of CD8+ lymphocytes.
Together with IL-2, IL-18 can also stimulate the pro-
duction of IL-13 and of other Th2 cytokines. Thus, it is
perhaps not surprising that IL-18 was found to be asso-
ciated with or demonstrated to contribute to numerous
inflammatory-associated disorders. These include infec-
tions, autoimmune diseases, rheumatoid arthritis, can-
cer, as well as metabolic syndrome and atherosclerosis
[5-11].
IL-18 had not originally been expected to cross an
intact blood brain barrier and its immunological effector
cells are not normally found in the healthy brain. Yet,
studies on the possible role of IL-18 in the central ner-
vous system (CNS), initiated soon after its cloning, were
prompted primarily by its similarities with IL-1, which
was already demonstrated to have central action. It was
soon found that IL-18 could be synthesized centrally
and its receptor subunits were now demonstrated to be
broadly expressed in neurons. When recombinant inter-
leukin 18 became available it also became clear that IL-
18 was active centrally. Work on mice null for IL-18 or
its receptor subunit alpha is helping to decipher the
action of this cytokine in the brain. Finally, the recent
discovery of novel IL-18 receptor subunits in the brain
has revealed the complexity of the IL-18 system and
may lead to better understanding of both the similarities
and opposing actions of IL-1 and IL-18. This review
summarizes more than a decade of work aimed at
understanding how the IL-18 system contributes to local
central inflammatory processes or can influence neuro-
nal function and behavior. A summary of the literature
supporting the involvement of IL-18 in neurophysiologi-
cal and neuropathological conditions is presented in
Table 1.
Components of the IL-18 system
IL-18 is synthesized as an inactive 24-kDa precursor
protein that is subsequently processed by caspase-1 into
its mature secretable form, which has a molecular
weight of 18 kDa [4,12-16]. Pro-IL-18 can also be pro-
cessed into its active form by various extracellular
enzymes including protease 3 (PR-3), serine protease,
elastase and cathepsin G [17-19]. Only the mature pep-
tide is reported to be biologically active.
The existence of a putative short isoform of IL-18
resulting from alternative splicing removing 57 bp/19 aa
was first described in rat adrenal glands (IL-18a) [20]
and subsequently in mouse spleens (IL-18s) [21]. Recom-
binant IL-18s did not display IL-18-like activity in stimu-
lating INF-g production when tested alone but appeared
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